References
- Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001;59:237-45. https://doi.org/10.1016/S0167-8140(01)00328-0
- Stieb S, Riesterer O, Brussow C, Pestalozzi B, Guckenberger M, Weiler S. Radiation recall dermatitis induced by sorafenib : A case study and review of the literature. Strahlenther Onkol 2016;192:342-8. https://doi.org/10.1007/s00066-016-0950-7
- Chung C, Dawson LA, Joshua AM, Brade AM. Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib. Anticancer Drugs 2010;21:206-9. https://doi.org/10.1097/CAD.0b013e328333d679
- Robbins J, Wollner I, Ryu S. Sorafenib induced radiation recall dermatitis after spine radiosurgery. J Radiosurg SBRT 2011;1:71-4.
- Hsieh CH, Lin SC, Shueng PW, Kuo DY. Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy. Onco Targets Ther 2014;7:1111-4.
- Oh D, Park HC, Lim HY, Yoo BC. Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction. Radiat Oncol J 2013;31:171-4. https://doi.org/10.3857/roj.2013.31.3.171
- Wilhelm SM, Carter C, Tang L, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 2004;64:7099-109. https://doi.org/10.1158/0008-5472.CAN-04-1443
- Bostrom A, Sjolin-Forsberg G, Wilking N, Bergh J. Radiation recall: another call with tamoxifen. Acta Oncol 1999;38:955-9. https://doi.org/10.1080/028418699432653
- Phillips TL, Fu KK. Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer 1976;37(2 Suppl):1186-200. https://doi.org/10.1002/1097-0142(197602)37:2+<1186::AID-CNCR2820370830>3.0.CO;2-V
- Oanta A, Irimie M. Radiation recall dermatitis induced by tamoxifen. Bull Transilvania Univ Brasov VI Med Sci 2012;5:113-6.
- Hsieh CH, Jeng KS, Lin CC, et al. Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma. Clin Drug Investig 2009;29:65-71. https://doi.org/10.2165/0044011-200929010-00007
- Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006;54:28-46. https://doi.org/10.1016/j.jaad.2005.08.054
- Yang CH, Lin WC, Chuang CK, et al. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy. Br J Dermatol 2008;158:592-6.
- Ding X, Ji W, Li J, Zhang X, Wang L. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer. Radiat Oncol 2011;6:24. https://doi.org/10.1186/1748-717X-6-24
- Schweitzer VG, Juillard GJ, Bajada CL, Parker RG. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer 1995;76:1069-72. https://doi.org/10.1002/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7
- Jeter MD, Janne PA, Brooks S, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 2002;53:394-400. https://doi.org/10.1016/S0360-3016(02)02773-6
- Levy A, Hollebecque A, Bourgier C, et al. Targeted therapyinduced radiation recall. Eur J Cancer 2013;49:1662-8. https://doi.org/10.1016/j.ejca.2012.12.009
- Ge J, Verma V, Hollander A, Langer C, Simone CB 2nd. Pemetrexed-induced radiation recall dermatitis in a patient with lung adenocarcinoma: case report and literature review. J Thorac Dis 2016;8:E1589-E1593. https://doi.org/10.21037/jtd.2016.12.102
- Ubukata M, Kamio T, Ohchi T, Noguchi E, Tsukada H, Kameoka S. Radiation recall dermatitis occurring 6 years and 4 months after breast-conserving surgery: a case report. Oncol Lett 2016;11:3071-4. https://doi.org/10.3892/ol.2016.4346
Cited by
- Sorafenib/tenofovir : Radiation recall dermatitis: case report vol.1680, pp.1, 2017, https://doi.org/10.1007/s40278-017-39241-3
- Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma vol.19, pp.2, 2017, https://doi.org/10.17998/jlc.19.2.136
- Radiation recall dermatitis after treatment of stage IV breast cancer with nivolumab: a case report vol.12, pp.2, 2017, https://doi.org/10.2217/imt-2019-0020